Dieter Blaas

Title: Dieter Blaas: Innovator in Pharmaceutical Composition

Introduction

Dieter Blaas is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the diagnosis and treatment of viral infections. With a total of 9 patents to his name, Blaas has established himself as a key figure in medical innovation.

Latest Patents

Among his latest patents is a method for diagnosing a rhinovirus infection. This invention relates to a pharmaceutical composition that includes at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues derived from a rhinovirus capsid protein. Another significant patent involves Picornavirus L proteinase and methods of making and using these peptides. This includes the expression of DNA encoding the Picornavirus L proteinase and its variants, as well as methods for determining active sites and inhibitors.

Career Highlights

Dieter Blaas has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Viravaxx GmbH. His work has focused on developing innovative solutions to combat viral infections, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Blaas has collaborated with esteemed colleagues such as Ernst Kuechler and Harald Mischak. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Dieter Blaas is a distinguished inventor whose work in pharmaceutical compositions has made a significant impact on the field of medicine. His innovative patents and collaborations highlight his dedication to improving healthcare solutions.